Churchill's New Capital Solutions Strategy Signals a Private Equity Exit Backlog That Won't Clear

TL;DR: On August 20, 2026, Churchill Asset Management launched a "Capital Solutions" strategy to lend directly to private-equity-backed middle-market companies, and the timing tells you more than the press release does. Churchill manages $66 billion in committed capital and sits inside the $99 billion Nuveen Private Capital platform alongside Arcmont Asset Management. Buyout holding periods have stretched to roughly seven years, up from five to six years between 2010 and 2021, according to Bain & Company's 2026 Global Private Equity Outlook. Nearly 40% of PE portfolio companies are now held more than five years. Churchill isn't launching a new lending category out of ambition. It's building a business around a bottleneck.

Here's the angle most coverage is missing: this isn't a story about one asset manager adding a product line. It's a story about what happens when an entire industry's exit machinery seizes up and debt providers step in to keep portfolio companies breathing without anyone admitting the fund is stuck. Capital Solutions strategies like Churchill's are becoming the release valve for a private equity system that can't sell what it owns fast enough. If you're an LP in buyout funds, or evaluating private credit, you need to understand this mechanism before your next fund letter uses phrases like "flexible financing" without explaining what's happening underneath.

The Data Behind the Launch

Start with the holding period numbers, because they're the whole reason this strategy exists. Bain's research, drawing on PitchBook and Preqin data, shows the average buyout holding period at exit has climbed to approximately seven years in 2026, up from five to six years for most of the 2010 to 2021 stretch. The unrealized asset stockpile sitting in buyout portfolios has grown to roughly 32,000 companies worth an estimated $3.8 trillion, per Bain's analysis. Distributions as a share of net asset value, one of the cleanest measures of cash GPs actually return to LPs, sat at 14% in Bain's most recent data, a level not seen since the 2008-2009 financial crisis.

Metric	2010-2021 baseline	2026 figure	Source
Average buyout holding period at exit	5-6 years	~7 years	Bain & Co
Portfolio companies held more than 5 years	29% (2019)	~40%	Bain & Co
Distributions as % of NAV	Historical average ~20%+	14%	Bain & Co / MSCI
Global private credit AUM	~$1 trillion (2020)	$2-3.2 trillion	Moody's / PIMCO

That combination, more companies stuck in portfolios longer and less cash flowing back to investors, is the structural setup Churchill is underwriting against. Jason Strife, Churchill's head of junior capital and private equity solutions, said it plainly in the firm's own announcement: "As private equity holding periods continue to extend, sponsors increasingly need financing partners that can provide greater flexibility for their portfolio companies." That's an accurate description of a market where sponsors can't sell and can't always call more equity from LPs, so they need someone to write debt into the portfolio company itself.

What Capital Solutions Actually Is (And Isn't)

This is where I want to be precise, because private credit terminology gets sloppy fast. A NAV loan, the kind LPs have been debating since 2023, is fund-level debt. The general partner borrows against the aggregate net asset value of the entire fund, typically through a special purpose vehicle sitting between the fund and its portfolio companies. That debt is cross-collateralized across every asset in the fund. If one portfolio company implodes, the lender's claim still touches the whole pool.

Churchill's Capital Solutions strategy, detailed in the firm's August 12, 2026 launch announcement, is structurally different. It lends at the asset level, directly to the individual portfolio company, not to the fund, investing primarily in senior secured debt with selective junior capital for balance sheet optimization, complex buyouts, add-on acquisitions, and maturity extensions. Each financing is underwritten against one company's cash flows and collateral, not a blended fund-wide net asset value calculation.

A NAV loan is the GP saying "trust the whole portfolio." A Capital Solutions deal is the GP saying "here's one company, help me finance its balance sheet so I don't have to sell it into a bad market." Both exist because of the same root cause, extended holds and a clogged exit market, but they carry different risk profiles for the LP sitting above them.

The Mechanism: Why Extended Holds Create Demand for This Product

Walk through the logic a sponsor faces in 2026. You bought a company in 2020 or 2021, near the top of the pricing cycle, at a rich multiple, and underwrote a five-year hold with an exit around 2025. The exit window didn't cooperate. Interest rates stayed higher for longer, strategic buyers got cautious, and IPO markets opened only for the biggest, cleanest names, like Hellman & Friedman's Verisure listing and the Medline offering that Bain flagged as the standout exits of the cycle. Everything below that top tier is sitting in the portfolio, aging.

Now you're holding that company for year six or seven instead of year five. The original debt package is approaching maturity. You don't want to sell into a soft market and lock in a mediocre return, and you don't want to call more capital from LPs who are already unhappy about distribution levels. What you need is a partner who can write new debt directly against that one company: refinancing a looming maturity, funding a bolt-on acquisition to grow into the multiple you paid, or simply buying time.

That's the exact use-case list Churchill and Connect Money both reported at launch, and every one is a symptom of a company that needs to keep growing or restructuring without a near-term sale. Noah Charney, who joined Churchill from King Street Capital Management after more than 13 years there including stints as head of capital solutions and head of capital markets, fits that thesis directly. He has spent his career structuring bespoke situations rather than plain-vanilla unitranche loans.

What This Means for LPs: Flexibility Versus Dilution

If you're an LP in the underlying PE funds, you're facing a real trade-off, not a free lunch. The flexibility benefit is straightforward: a well-structured asset-level facility can keep a good company out of a fire sale, fund growth that increases eventual exit value, and buy time for conditions to improve. Nobody wants their fund to be a forced seller into a bad market. The dilution and risk side is less obvious, and it doesn't show up in a fund's headline IRR.

First, more debt at the portfolio company level stacks new leverage on top of leverage already put there at the original buyout. Layering on additional senior secured or junior capital increases the debt service burden and shrinks the equity cushion if the company underperforms. The Institutional Limited Partners Association flagged this exact concern for fund-level NAV facilities in its 2024 guidance on NAV-based facilities, warning that added leverage above the portfolio company level can be opaque to LPs and can compromise the return differentiation LPs pay private equity fees to access. Asset-level Capital Solutions financing doesn't carry the same fund-wide cross-collateralization risk ILPA flagged, but it still adds debt claims ahead of the sponsor's equity, exactly where LP economics live.

Second, there's a transparency gap. New financing at a portfolio company doesn't always get the same LP Advisory Committee scrutiny that fund-level NAV facilities increasingly require. Chronograph's research on NAV loan considerations found that 80% of North American LPs surveyed by Capstone Partners give only partial credit, and 14% give none at all, to distributions enabled by fund-level financing tools. That skepticism should extend to asset-level solutions used to prop up a valuation rather than fund growth. A healthy company doing an accretive add-on and a distressed company refinancing out of a maturity wall can both show up in a GP's letter as "we partnered with a flexible capital provider." The label doesn't tell you which one you're looking at, and if a company needs new debt just to survive, an LP should ask why the fund isn't marking that asset down instead.

What It Signals About the PE Exit Backlog

Zoom out and this launch is a data point in a bigger story. Global private credit assets under management have grown past $2 trillion and are heading toward $3.4 trillion by 2030 under PwC's base case, according to PwC's 2026 Private Credit Survey. Moody's projects the market approaching $4 trillion by 2030, per its 2026 private credit outlook, and calls out NAV lending as a growth engine. Private credit isn't just growing because investors want yield. It's growing because private equity's own exit machinery is broken enough that a new category of lender is needed to keep portfolio companies functioning inside funds that can't sell them.

When one of the largest private credit platforms in the country builds an entire strategy, hires a dedicated managing director, and stands up an investment committee specifically to finance companies stuck in extended holds, that's an admission the exit backlog isn't a temporary blip. Bain's Private Equity Midyear Report 2026 calls the current environment an "implied capital cycle" of roughly seven years, a structural shift, not a one-year anomaly tied to a single rate cycle.

Named Example: Why This Differs From Vista's Finastra NAV Loan

It's worth contrasting Churchill's model against a well-known fund-level example. Vista Equity Partners used a NAV loan to refinance debt at Finastra, one of its portfolio companies, a transaction widely cited in the NAV lending debate because it showed how fund-level financing could restructure a heavily indebted asset's balance sheet without a sale. That was leverage secured against the broader fund's asset base.

Churchill's Capital Solutions strategy does something adjacent but structurally cleaner: it originates that same kind of maturity-extension financing directly at the portfolio company, without routing it through a fund-wide facility. Asset-level financing keeps the risk contained to one company's capital structure, while fund-level NAV financing spreads the risk, and the lender's claim, across the entire portfolio. Churchill's own materials note it will provide first lien, unitranche, second lien, and mezzanine debt across the capital structure, meaning the risk profile of any individual deal will vary widely. LPs shouldn't treat "Capital Solutions" as a single risk category.

Jeff's Take: The Risk Headline Returns Don't Show

In my experience covering private credit's expansion into the leveraged buyout stack, the pattern is always the same. A structural problem emerges, in this case sponsors stuck holding companies too long in a soft exit market. A new lending category shows up to solve it. Everyone frames it as a flexibility tool for sponsors and a yield opportunity for credit investors. Nobody frames it plainly: additional leverage on top of companies that are already leveraged buyouts, financed by lenders who get paid whether or not the underlying equity thesis ever plays out.

I'm not saying Capital Solutions strategies are bad. Churchill has underwritten middle-market credit across cycles for years, and asset-level financing that funds a genuine growth acquisition is a different animal than debt used to paper over a failing thesis. But here's what won't show up in the fund's headline IRR: the interest expense on every dollar of new debt sits ahead of the sponsor's equity and, by extension, ahead of your LP interest in the fund's return waterfall. If the extended hold works out, that debt looks like smart bridge financing. If it doesn't, you've added another layer of fixed claims on a company already carrying buyout-level leverage, and the equity cushion protecting your LP interest just got thinner. That risk is spreading across a growing share of the roughly 32,000 unrealized portfolio companies Bain has identified, and it won't show up in a fund's reported multiple on invested capital until the exit happens.

What to Do With This Information

If you're an LP in buyout funds, the next quarterly report mentioning a portfolio company "partnering with a capital solutions provider" deserves a direct follow-up to your GP: is this asset-level or fund-level, what's the use of proceeds, and does the LP Advisory Committee have visibility into the terms? If you're evaluating private credit as an allocation, understand that strategies like Churchill's underwrite a specific, identifiable risk: extended hold periods and exit market dysfunction. That risk is priced into the yield you'd earn as a credit investor. Read the fine print on what tier of the capital structure you're exposed to before treating private credit as a single asset class.

Frequently Asked Questions

What is Churchill's Capital Solutions strategy?

It's a private credit strategy launched by Churchill Asset Management on August 20, 2026, that provides customized financing directly to private-equity-backed middle-market companies. It invests primarily in senior secured debt, with selective junior capital, to fund balance sheet optimization, complex buyouts, add-on acquisitions, and maturity extensions. Noah Charney leads the strategy as managing director and head of Capital Solutions.

How is Capital Solutions financing different from a fund-level NAV loan?

A NAV loan is borrowed against the aggregate net asset value of an entire private equity fund, typically through a special purpose vehicle, and is cross-collateralized across every portfolio company in that fund. Capital Solutions financing, as Churchill has structured it, lends directly to an individual portfolio company against that company's own cash flows and collateral, keeping the credit risk contained to one asset rather than spread across the fund.

Why are private equity holding periods extending, and why does it matter for LPs?

Buyout holding periods have stretched to roughly seven years in 2026, up from five to six years between 2010 and 2021, according to Bain & Company, driven by soft exit markets, higher-for-longer interest rates, and valuation gaps between buyers and sellers. It matters for LPs because distributions as a share of net asset value have fallen to levels not seen since the 2008-2009 financial crisis, meaning capital that should be returned to investors is instead trapped in aging portfolio companies.

Does financing like this increase risk for LPs already invested in the underlying funds?

Yes, in a way that doesn't always show up in headline fund performance. Additional debt at the portfolio company level increases leverage on top of the original buyout debt, which thins the equity cushion protecting the LP's economic interest if the company underperforms. LPs should ask their general partners whether specific financings are funding genuine growth or simply extending the life of a struggling investment.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.